Intravenous Immunoglobulin (IVIg) Market Report

Europe Intravenous Immunoglobulin (IVIg) Market Size, Status and Forecast 2014-2026

  • POSTDATE：May 29, 2020
  • PAGES：204
  • REPORT CODE：GMM532507
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Intravenous Immunoglobulin (IVIg) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Intravenous Immunoglobulin (IVIg) Market Segmentations:

    By Player:

    • Grifols

    • Hualan Bio

    • Kedrion

    • Baxter

    • Octapharma

    • Biotest

    • CNBG

    • CSL

    • Sichuan Yuanda Shuyang

    • Shanghai RAAS

    • CBPO

    • BPL

    • LFB Group

    By Type:

    • IVIg Liquid

    • IVIg Powder

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulin (IVIg) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid from 2014 to 2026

    • 1.3.2 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2014 to 2026

    • 1.4.2 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2014 to 2026

    • 1.4.3 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Intravenous Immunoglobulin (IVIg) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major Types

      • 3.4.1 Market Size and Growth Rate of IVIg Liquid

      • 3.4.2 Market Size and Growth Rate of IVIg Powder

    4 Segmentation of Intravenous Immunoglobulin (IVIg) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Immunodeficiency for Construction

      • 4.4.2 Market Size and Growth Rate of Autoimmune Disease for Construction

      • 4.4.3 Market Size and Growth Rate of Acute Infection for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Intravenous Immunoglobulin (IVIg) Production Analysis by Top Regions

    • 5.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Analysis by Top Regions

    • 5.3 Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Intravenous Immunoglobulin (IVIg) Market among Top Countries

    • 6.1 Top 5 Export Countries in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 7.1 Germany Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 7.2 Germany Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    8. UK Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 8.1 UK Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 8.2 UK Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    9. France Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 9.1 France Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 9.2 France Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    10. Italy Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 10.1 Italy Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 10.2 Italy Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    11. Spain Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 11.1 Spain Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 11.2 Spain Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    12. Poland Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 12.1 Poland Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 12.2 Poland Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    13. Russia Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 13.1 Russia Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 13.2 Russia Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    14. Switzerland Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 14.1 Switzerland Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 14.2 Switzerland Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    15. Turkey Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 15.1 Turkey Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 15.2 Turkey Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 16.3.2 Finland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 16.3.3 Norway Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 16.3.4 Sweden Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 16.3.6 Iceland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 17.3.2 Netherlands Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 18.3.2 Latvia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 18.3.3 Lithuania Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Grifols

      • 19.1.1 Grifols Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Hualan Bio

      • 19.2.1 Hualan Bio Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Kedrion

      • 19.3.1 Kedrion Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Baxter

      • 19.4.1 Baxter Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Octapharma

      • 19.5.1 Octapharma Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Biotest

      • 19.6.1 Biotest Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 CNBG

      • 19.7.1 CNBG Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 CSL

      • 19.8.1 CSL Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Sichuan Yuanda Shuyang

      • 19.9.1 Sichuan Yuanda Shuyang Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Shanghai RAAS

      • 19.10.1 Shanghai RAAS Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 CBPO

      • 19.11.1 CBPO Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 BPL

      • 19.12.1 BPL Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 LFB Group

      • 19.13.1 LFB Group Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 85 Figures and 198 Tables)

    • Figure Product Picture

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid Market, 2015 - 2026 (USD Million)

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder Market, 2015 - 2026 (USD Million)

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2014 to 2026

    • Figure Germany Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure France Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Intravenous Immunoglobulin (IVIg) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Intravenous Immunoglobulin (IVIg)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different Types from 2014 to 2026

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different Types from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid Market, 2015 - 2026 (USD Million)

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2014 to 2026

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Production by Major Regions

    • Table Europe Intravenous Immunoglobulin (IVIg) Production Share by Major Regions

    • Figure Europe Intravenous Immunoglobulin (IVIg) Production Share by Major Countries and Regions in 2014

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Major Regions

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions

    • Table Germany Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table UK Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table France Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Italy Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Spain Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Poland Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Russia Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Switzerland Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Turkey Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Germany Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Germany Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Germany Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table UK Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table UK Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table UK Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table UK Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table France Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table France Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table France Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table France Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Italy Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Italy Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Italy Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Spain Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Spain Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Spain Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Poland Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Poland Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Poland Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Russia Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Russia Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Russia Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Switzerland Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Turkey Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Turkey Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Turkey Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Grifols Profiles

    • Table Grifols Production, Value, Price, Gross Margin 2014-2019

    • Table Grifols Product benchmarking

    • Table Grifols Strategic initiatives

    • Table Grifols SWOT analysis

    • Table Hualan Bio Profiles

    • Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Hualan Bio Product benchmarking

    • Table Hualan Bio Strategic initiatives

    • Table Hualan Bio SWOT analysis

    • Table Kedrion Profiles

    • Table Kedrion Production, Value, Price, Gross Margin 2014-2019

    • Table Kedrion Product benchmarking

    • Table Kedrion Strategic initiatives

    • Table Kedrion SWOT analysis

    • Table Baxter Profiles

    • Table Baxter Production, Value, Price, Gross Margin 2014-2019

    • Table Baxter Product benchmarking

    • Table Baxter Strategic initiatives

    • Table Baxter SWOT analysis

    • Table Octapharma Profiles

    • Table Octapharma Production, Value, Price, Gross Margin 2014-2019

    • Table Octapharma Product benchmarking

    • Table Octapharma Strategic initiatives

    • Table Octapharma SWOT analysis

    • Table Biotest Profiles

    • Table Biotest Production, Value, Price, Gross Margin 2014-2019

    • Table Biotest Product benchmarking

    • Table Biotest Strategic initiatives

    • Table Biotest SWOT analysis

    • Table CNBG Profiles

    • Table CNBG Production, Value, Price, Gross Margin 2014-2019

    • Table CNBG Product benchmarking

    • Table CNBG Strategic initiatives

    • Table CNBG SWOT analysis

    • Table CSL Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table CSL Product benchmarking

    • Table CSL Strategic initiatives

    • Table CSL SWOT analysis

    • Table Sichuan Yuanda Shuyang Profiles

    • Table Sichuan Yuanda Shuyang Production, Value, Price, Gross Margin 2014-2019

    • Table Sichuan Yuanda Shuyang Product benchmarking

    • Table Sichuan Yuanda Shuyang Strategic initiatives

    • Table Sichuan Yuanda Shuyang SWOT analysis

    • Table Shanghai RAAS Profiles

    • Table Shanghai RAAS Production, Value, Price, Gross Margin 2014-2019

    • Table Shanghai RAAS Product benchmarking

    • Table Shanghai RAAS Strategic initiatives

    • Table Shanghai RAAS SWOT analysis

    • Table CBPO Profiles

    • Table CBPO Production, Value, Price, Gross Margin 2014-2019

    • Table CBPO Product benchmarking

    • Table CBPO Strategic initiatives

    • Table CBPO SWOT analysis

    • Table BPL Profiles

    • Table BPL Production, Value, Price, Gross Margin 2014-2019

    • Table BPL Product benchmarking

    • Table BPL Strategic initiatives

    • Table BPL SWOT analysis

    • Table LFB Group Profiles

    • Table LFB Group Production, Value, Price, Gross Margin 2014-2019

    • Table LFB Group Product benchmarking

    • Table LFB Group Strategic initiatives

    • Table LFB Group SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US